The MEDICREA Group Company Profile

12:03 EDT 18th June 2019 | BioPortfolio

News Articles [666 Associated News Articles listed on BioPortfolio]

Medicrea gets $30mm in notes financing from Perceptive Advisors

Medicrea International SA (devices for spinal surgery) secured $30mm in four-year senior notes from Perceptive Advisors. Concurrently Medicrea has issued Perceptive Advisors warrants for new ordinary ...

Medicrea Reports Third-Quarter Results

Third quarter sales increased by 14% Gross margin improved to 73% Positive EBITDA generated in the third-quarter Net loss reduced by 45% ...

Medicrea Reports 2018 Fourth Quarter and Annual Sales Confirmation of Strong Growth Momentum

Fourth quarter sales: +30% (at constant exchange rate)Annual sales: +22% (at constant exchange rate)Fourth quarter UNiD ASI ™ personalized surgeries in the US: + 94% ...

Medicrea Reports First Quarter 2019 Sales


MEDICREA® Secures Several New Patents to Protect its Proprietary platform technology UNiD ASI

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence,...

Medicrea Hosts Second Annual Meeting Focused on Artificial Intelligence and Analytics in New York, USA

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence...

Medicrea announces closing of $30M offering

An offering of senior secured and guaranteed notes involving investment firm Perceptive Advisors has pulled in $30 million fo -More- 

Medicrea Reports 2018 Annual Results

2018 Annual Sales: € 32.3M, +22% at Constant Exchange RateStrong Growth of UNiD® Surgeries in the USA: +67%Gross Margin Jumping to 77% in the 4th QuarterEBITDA at Break-...

Drugs and Medications [0 Results]


PubMed Articles [1651 Associated PubMed Articles listed on BioPortfolio]

Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan.

The 2017 GOLD ABCD classification shifts patients from groups C-D to A-B. Group A was the most widely distributed group in several studies. It would be useful to understand the characteristics for gro...

Appearance of large scavenger receptor A-positive cells in peripheral blood: A potential risk factor for severe exacerbation of chronic obstructive pulmonary disease.

Fresh peripheral blood (PB) samples from 432 outpatients with stable chronic obstructive pulmonary disease (COPD) were examined. Patients were classified into Group A (large SRA cells were undetected)...

The apoptotic effects of bisphenol A exposure on the rat ovary: an experimental study.

Bisphenol A (BPA) is a key endocrine-disrupting chemical (EDC) in the manufacturing industry. It is found in the structure of compounds such as polycarbonate and epoxy in combination with other chemic...

Lamina cribrosa morphology in glaucomatous eyes with hemifield defect in a Korean population.

To compare regional variations in lamina cribrosa (LC) curvature and depth between healthy eyes (Group 1) and naïve eyes with primary open-angle glaucoma (POAG) having superior (Group 2), inferior (G...

New stoichiometric compounds of Au-Hg system under high pressure.

We have extensively explored Au-Hg system under high pressure in the range of 0-300 GPa with and without spin-orbit coupling (SOC) inclusion. The variable-composition methodology has been used as empl...

Clinical Trials [4569 Associated Clinical Trials listed on BioPortfolio]

Personalized Spine Study Group Registry

As a registry, the primary objective of the study is a data collection initiative. The study will collect clinical and radiographic outcomes of patients implanted with Medicrea's PSR. The ...

O-arm Assessment of Vertebral Movement Using ST2R Technique

The study is quantifying how your back has been corrected using Medicrea's hardware through imaging taken before, during, and after your surgery. Visits include the pre-operative visit, 1 ...

MAC-cbt Group Therapy for Adults With ADHD

The study is developed to validate a new short psychotherapeutic group treatment for adults with ADHD diagnosis. The participants will be treated in a monocentric, parallel group randomize...

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Companies [1676 Associated Companies listed on BioPortfolio]


Through the lens of predictive medicine, MEDICREA® leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive c...


MEDICREA is a French company fully dedicated to the design of surgical devices for 15 years. Its outstanding knowledge in design and manufacturing is recognised worldwide. The complete range of patent...



The Medicrea® Group

More Information about "The MEDICREA Group" on BioPortfolio

We have published hundreds of The MEDICREA Group news stories on BioPortfolio along with dozens of The MEDICREA Group Clinical Trials and PubMed Articles about The MEDICREA Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The MEDICREA Group Companies in our database. You can also find out about relevant The MEDICREA Group Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record